These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

569 related items for PubMed ID: 16682315

  • 1. The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy.
    Nikolaidis LA, Poornima I, Parikh P, Magovern M, Shen YT, Shannon RP.
    J Am Coll Cardiol; 2006 May 02; 47(9):1871-81. PubMed ID: 16682315
    [Abstract] [Full Text] [Related]

  • 2. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart.
    Gilbert EM, Abraham WT, Olsen S, Hattler B, White M, Mealy P, Larrabee P, Bristow MR.
    Circulation; 1996 Dec 01; 94(11):2817-25. PubMed ID: 8941107
    [Abstract] [Full Text] [Related]

  • 3. Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.
    Nikolaidis LA, Elahi D, Hentosz T, Doverspike A, Huerbin R, Zourelias L, Stolarski C, Shen YT, Shannon RP.
    Circulation; 2004 Aug 24; 110(8):955-61. PubMed ID: 15313949
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol.
    Metra M, Giubbini R, Nodari S, Boldi E, Modena MG, Dei Cas L.
    Circulation; 2000 Aug 01; 102(5):546-51. PubMed ID: 10920067
    [Abstract] [Full Text] [Related]

  • 5. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS, Munger M, Macgregor J, Lombardi WL, Stoddard GP, Gilbert EM.
    Pharmacotherapy; 2009 Aug 01; 29(8):883-90. PubMed ID: 19637941
    [Abstract] [Full Text] [Related]

  • 6. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.
    J Am Coll Cardiol; 2010 Apr 27; 55(17):1780-7. PubMed ID: 20413026
    [Abstract] [Full Text] [Related]

  • 7. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A, Azevedo ER, Floras JS, Hollingshead S, Lopaschuk GD, Parker JD.
    Eur J Heart Fail; 2005 Jun 27; 7(4):618-23. PubMed ID: 15921803
    [Abstract] [Full Text] [Related]

  • 8. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
    Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D, Wolfel EE, Lindenfeld J, Tsvetkova T, Robertson AD, Quaife RA, Bristow MR.
    N Engl J Med; 2002 May 02; 346(18):1357-65. PubMed ID: 11986409
    [Abstract] [Full Text] [Related]

  • 9. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E, Kurum T.
    Can J Cardiol; 2005 Mar 15; 21(4):344-8. PubMed ID: 15838561
    [Abstract] [Full Text] [Related]

  • 10. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
    Hryniewicz K, Androne AS, Hudaihed A, Katz SD.
    Circulation; 2003 Aug 26; 108(8):971-6. PubMed ID: 12912816
    [Abstract] [Full Text] [Related]

  • 11. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
    Hanada K, Asari K, Saito M, Kawana J, Mita M, Ogata H.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):194-200. PubMed ID: 18534575
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of beta-blockers on left ventricular dyssynchrony and reverse remodeling in idiopathic dilated cardiomyopathy: A randomized trial of carvedilol and metoprolol.
    Kaya MG, Sarli B, Akpek M, Kaya EG, Yarlioglues M, Topsakal R, Lam YY.
    Cardiol J; 2014 Jul 28; 21(4):434-41. PubMed ID: 24142686
    [Abstract] [Full Text] [Related]

  • 14. [Effect of beta-blockers metoprolol CR/XL and carvedilol on left ventricular contractility in patients with chronic low cardiac output].
    Syrkin AL, Kukes VG, Poltavskaia MG, Andreev DA, Aref'eva AB, Teplonogova EV, Konova IA, Rykova MS.
    Ter Arkh; 2003 Jul 28; 75(9):73-7. PubMed ID: 14582439
    [Abstract] [Full Text] [Related]

  • 15. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
    Chen L, Meyers D, Javorsky G, Burstow D, Lolekha P, Lucas M, Semmler AB, Savarimuthu SM, Fong KM, Yang IA, Atherton J, Galbraith AJ, Parsonage WA, Molenaar P.
    Pharmacogenet Genomics; 2007 Nov 28; 17(11):941-9. PubMed ID: 18075464
    [Abstract] [Full Text] [Related]

  • 16. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
    Torp-Pedersen C, Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lutiger B, Metra M, Remme WJ, Scherhag A, Skene A, COMET Investigators.
    Am Heart J; 2005 Feb 28; 149(2):370-6. PubMed ID: 15846279
    [Abstract] [Full Text] [Related]

  • 17. Second- and third-generation beta-blocking drugs in chronic heart failure.
    Bristow MR, Abraham WT, Yoshikawa T, White M, Hattler BG, Crisman TS, Lowes BD, Robertson AD, Larrabee P, Gilbert EM.
    Cardiovasc Drugs Ther; 1997 May 28; 11 Suppl 1():291-6. PubMed ID: 9211023
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.
    Remme WJ, Torp-Pedersen C, Cleland JG, Poole-Wilson PA, Metra M, Komajda M, Swedberg K, Di Lenarda A, Spark P, Scherhag A, Moullet C, Lukas MA.
    J Am Coll Cardiol; 2007 Mar 06; 49(9):963-71. PubMed ID: 17336720
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.